The Veterinary Medicines (Amendment etc.) Regulations 2024

Amendment to paragraph 1

162.  In paragraph 1 (interpretation)—

(a) the existing text is renumbered as sub-paragraph (1);

(b) in sub-paragraph (1), in the definition of “pharmaceutical product”, at the end insert “or a biological veterinary medicinal product that is not immunological”;

(c) after that sub-paragraph insert—

“(2) For the purposes of this Schedule “manufacturing authorisation” means the following activities—

(a) manufacture or import of an authorised veterinary medicinal product;

(b) manufacture of a product to which paragraph 2 of Schedule 6 relates;

(c) manufacture of a product for administration under the cascade;

(d) manufacture of—

(i) an autogenous vaccine;

(ii) a stem cell product; or

(iii) a blood product for administration to non-food animals.”.